Ingevity Corp (NGVT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Ingevity Corp stock (NGVT) is currently trading at $71.78. Ingevity Corp PS ratio (Price-to-Sales) is 2.10. Analyst consensus price target for NGVT is $79.25. WallStSmart rates NGVT as Sell.
- NGVT PE ratio analysis and historical PE chart
- NGVT PS ratio (Price-to-Sales) history and trend
- NGVT intrinsic value — DCF, Graham Number, EPV models
- NGVT stock price prediction 2025 2026 2027 2028 2029 2030
- NGVT fair value vs current price
- NGVT insider transactions and insider buying
- Is NGVT undervalued or overvalued?
- Ingevity Corp financial analysis — revenue, earnings, cash flow
- NGVT Piotroski F-Score and Altman Z-Score
- NGVT analyst price target and Smart Rating
Ingevity Corp
📊 No data available
Try selecting a different time range
Smart Analysis
Ingevity Corp (NGVT) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in institutional own.. Concerns around return on equity and price/book. Significant fundamental concerns warrant caution or avoidance.
Ingevity Corp (NGVT) Key Strengths (2)
108.63% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Ingevity Corp (NGVT) Areas to Watch (8)
Company is destroying shareholder value
Revenue declining -14.60%, a shrinking business
Earnings declining -65.20%, profits shrinking
Company is losing money with a negative profit margin
Very expensive at 82.4x book value
Paying a premium for growth, expensive relative to earnings expansion
Decent operational efficiency, solid but not exceptional
Revenue is fairly priced at 2.10x sales
Ingevity Corp (NGVT) Detailed Analysis Report
Overall Assessment
This company scores 33/100 in our Smart Analysis, earning a F grade. Out of 10 metrics analyzed, 2 register as strengths (avg 8.5/10) while 8 fall into concern territory (avg 2.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Market Cap.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, EPS Growth. Some valuation metrics including PEG Ratio (2.41), Price/Sales (2.10), Price/Book (82.42) suggest expensive pricing. Growth concerns include Revenue Growth at -14.60%, EPS Growth at -65.20%, which may limit upside. Profitability pressure is visible in Return on Equity at -133.70%, Operating Margin at 15.20%, Profit Margin at -14.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -133.70% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -14.60% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
NGVT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
NGVT's Price-to-Sales ratio of 2.10x sits near its historical average of 1.94x (60th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 44% below its historical high of 3.77x set in Sep 2018, and 192% above its historical low of 0.72x in Oct 2024. Over the past 12 months, the PS ratio has expanded from ~1.0x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Ingevity Corp (NGVT) · BASIC MATERIALS › SPECIALTY CHEMICALS
The Big Picture
Ingevity Corp is in a turnaround phase, with management focused on restoring profitability. Revenue reached 1.2B with 15% decline year-over-year. The company is currently unprofitable, posting a -14.3% profit margin.
Key Findings
Generating 74M in free cash flow and 97M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 15% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -14.3% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor SPECIALTY CHEMICALS industry trends, competitive moves, and regulatory changes that could impact Ingevity Corp.
Bottom Line
Ingevity Corp is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(40 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 10:00:42 AM
About Ingevity Corp(NGVT)
NYSE
BASIC MATERIALS
SPECIALTY CHEMICALS
USA
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, Asia-Pacific, Europe, the Middle East, Africa, and South America. The company is headquartered in North Charleston, South Carolina.